Crohns Disease
Conditions
Brief summary
The investigators will prospectively recruit 26 children with moderate - severe active Crohn disease (PCDAI \>30). Results will be compared to 26 patients in sustained remission (PCDAI \<10 and physician global assessment of remission over the previous 6 months) who are matched for age and gender. Subjects will be studied at baseline and six months. The primary study end-points will be leucine rate of appearance (a measure of protein breakdown) and IGF-1 levels. This study will test the hypothesis that children with greater disease severity will have worse longitudinal growth and protein catabolism. The investigators will also explore the secondary hypothesis that children with Crohn disease have abnormal IGF-1 generation which is linked to underlying inflammation and disease severity.
Interventions
OTHERExaminations
Growth hormone stimulation testing, Protein turnover, Dexa scan, Bone age x-ray
Sponsors
Nationwide Children's Hospital
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
5 Years to 15 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosed with Crohn disease by endoscopy and histologic samples * Chronological and/or bone age 6-15 years old * Tanner 1 - 2 * Willing to participate in our longitudinal evaluation
Exclusion criteria
* Concomitant persistent chronic infectious disease * Inflammatory bowel disease not diagnosed as Crohn disease * Immunological disorder (excluding Crohn disease) * Associated severe concomitant chronic illnesses (CF, liver failure) * Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Height velocity | 6 months |
Secondary
| Measure | Time frame |
|---|---|
| Protein catabolism | 6 months |
Countries
United States
Outcome results
None listed